CD4+组织驻留记忆Th17细胞是脊柱关节炎滑膜组织中IL-17A的主要来源
该研究采用单细胞RNA测序和空间RNA分析脊柱关节炎(AxSpA与PsA)患者滑膜组织,发现CD4+CXCR6+组织驻留记忆Th17(TRM17)细胞是IL-17A的主要自发产生者,并与活化的CLEC10A+树突状细胞相互作用;体外生成的TRM17样细胞经TCR刺激产生IL-17A/F,表观调控因子BRD1参与TRM17生成。
要点
- CD4+CXCR6+ TRM17细胞是SpA滑膜中IL-17A的主要自发产生细胞。
- TRM17与活化的CLEC10A+树突状细胞存在细胞间通讯及空间邻近。
- BRD1参与CD4+ TRM17样细胞的生成,敲低BRD1可抑制其产生。
核心结论
- CD4+ TRM17细胞是SpA滑膜组织中IL-17A的主要来源。
- TCR刺激是CD4+ TRM17样细胞分泌IL-17A所必需的。
- 表观调控因子BRD1参与CD4+ TRM17的生成。
- 作者认为清除SpA中的CD4+ TRM17细胞是一种有潜力诱导长期缓解的治疗策略。
研究设计与样本
- 对SpA患者滑膜组织进行单细胞RNA测序(AxSpA,n=5;PsA,n=6)或空间RNA分析(PsA,n=4)。
- 使用CellPhoneDB推断细胞间通讯。
- 利用SpA患者外周血记忆CD4+ T细胞体外生成TRM17样细胞。
- 使用表观遗传抑制剂文库、siRNA和CRISPR鉴定TRM17的表观调控因子。
主要发现
- 单细胞RNA测序显示CD4+CXCR6+ TRM17细胞是SpA滑膜中IL-17A的主要自发产生细胞。
- 细胞间通讯和单细胞空间分析支持TRM17与SpA中活化的CLEC10A+树突状细胞之间的相互作用。
- SpA滑膜中衬里和衬下成纤维细胞均显示IL-17A活化的证据。
- 体外生成的CD4+ TRM17样细胞在表型上模拟关节组织TRM17,经TCR刺激产生IL-17A/F,且该过程被细胞因子进一步增强。
- 扰动BRD1可抑制TRM17样细胞的生成。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Interleukin (IL)-17A is a key driver of spondyloarthritis (SpA) joint pathology. We aimed to identify its cellular source in synovial tissue from patients with 2 forms of SpA, namely axial SpA (AxSpA) and psoriatic arthritis (PsA). METHODS: Synovial tissue from patients with SpA was profiled using single-cell RNA sequencing (scRNA-seq; AxSpA, n = 5; PsA, n = 6) or spatial RNA profiling (PsA, n = 4). CellPhoneDB was used to infer cell-cell communication. Tissue-resident memory Th17 (TRM17)-like cells were generated in vitro using blood memory CD4+ T cells from SpA patients. An epigenetic inhibitor library, siRNA, and clustered regularly interspaced short palindromic repeats (CRISPR) were used to identify epigenetic regulator(s) for TRM17. RESULTS: scRNA-seq showed that CD4+CXCR6+ TRM17 cells are the predominant spontaneous IL17A producers in SpA synovium. Cell-cell communication and single-cell spatial analysis support the interaction between TRM17 and CLEC10A+ dendritic cells, which were activated in SpA. Both sublining and lining fibroblasts in SpA synovium showed evidence of interleukin (IL)-17A activation. In vitro-generated CD4+ TRM17-like cells phenocopied joint tissue TRM17, producing IL-17A/F upon T cell-receptor (TCR) stimulation, which was further enhanced by cytokines. Perturbation of BRD1 inhibited the generation of TRM17-like cells. CONCLUSIONS: CD4+ TRM17 cells are the predominant source of IL-17A in SpA synovial tissue. TCR stimulation is essential for the secretion of IL-17A by CD4+TRM17-like cells. The epigenetic regulator bromodomain-containing protein 1 (BRD1) contributes to the generation of CD4+TRM17. Depleting CD4+TRM17 cells in SpA is thus a therapeutic strategy with potential to induce long-term remission.
引用
- Liu F, Shi H, Turner JD, et al. CD4+ tissue-resident memory Th17 cells are a major source of IL-17A in Spondyloarthritis synovial tissue. Ann Rheum Dis. 2025. PMID: 40413112. doi:10.1016/j.ard.2025.04.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。